Skip to content
WeighLab

Claya vs Näky

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Claya

Provider comparison

Shoppers who want one semaglutide price at any dose and will consider a multi-month prepay to get the advertised rate.

Semaglutide / month
$149/moAll doses, compounded
Tirzepatide / month
$199/moSame price regardless of dose; select multi-month plans, compounded
Index 72/100 · Grade CChecked October 2026

Näky

Provider comparison

Shoppers comparing compounded injections with brand-name oral GLP-1 options and published plan-length prices.

Semaglutide / month
$185/moMonth to month, any dose, compounded
Tirzepatide / month
$295/moMonth to month, any dose, compounded
Index 72/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 72/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Claya

Näky

Semaglutide / month
Claya: $149/moAll doses, compounded
Näky: $185/moMonth to month, any dose, compounded
Tirzepatide / month
Claya: $199/moSame price regardless of dose; select multi-month plans, compounded
Näky: $295/moMonth to month, any dose, compounded
Semaglutide / year (modeled)
Claya: $1,788
Näky: $2,220
Tirzepatide / year (modeled)
Claya: $2,388
Näky: $3,540
State availability
Claya: Coverage not published
Näky: Coverage not published
Oral / sublingual option listed
Claya: Yes
Näky: Yes
Brand-name access listed
Claya: Yes
Näky: Yes
Provider facts checked
Claya: October 2026
Näky: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Claya

Shoppers who want one semaglutide price at any dose and will consider a multi-month prepay to get the advertised rate.

Reasons to consider it

  • Both injections are described as the same price regardless of dosage
  • LegitScript, BBB and HIPAA badges are displayed
  • Offers brand-name Ozempic, Zepbound and Mounjaro routes alongside compounded options

What to weigh up

  • The $149/$199 rates are qualified as available with select multi-month plans; confirm the term and total before paying
  • No state coverage list is published
  • No individual prescriber or medical director is named

Näky

Shoppers comparing compounded injections with brand-name oral GLP-1 options and published plan-length prices.

Reasons to consider it

  • Brand-name Wegovy and Foundayo pills are offered separately from compounded injections, with the dose prices and additional membership shown
  • Separate semaglutide and tirzepatide microdose programs are listed; ask the prescriber which treatment fits
  • LegitScript verification is displayed and checkable for its own website

What to weigh up

  • The advertised $145 semaglutide and $265 tirzepatide rates require six months prepaid; month-to-month rates are $185 and $295
  • Brand-name pill prices exclude a required $125 monthly membership; add it to the dose-specific medication charge
  • Naky Health LLC is named, but its state list, dispensing pharmacies and medical director are not published

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

ClayaNäky
Normalized Cost/Month
Claya:
81/100
Näky:
80/100
Price Transparency
Claya:
94/100
Näky:
94/100
Nationwide Access
Claya:
24/100
Näky:
24/100
Formulation Options
Claya:
90/100
Näky:
90/100
Clinical Oversight
Claya:
82/100
Näky:
81/100
Contract Flexibility
Claya:
53/100
Näky:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.